News Industry News 4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec July 20, 2017
News Industry News 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum June 16, 2017
News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Industry News 4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum June 08, 2017
News Conference News EuroPCR 2017 EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure Michael O'Riordan May 24, 2017
News Daily News Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke Todd Neale May 24, 2017
News Conference News EuroPCR 2017 More Early Stroke With SAVR Than TAVR in SURTAVI Shelley Wood May 18, 2017
News Conference News EuroPCR 2017 The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone Yael L. Maxwell May 17, 2017
News Daily News ‘Reassuring’ Results for Watchman LAA Closure Device Seen in EWOLUTION Registry Todd Neale May 17, 2017
News Conference News SCAI 2017 New-Onset A-fib After TAVR Linked to Increased Risk of Early Stroke L.A. McKeown May 12, 2017
Presentation SWVS 2017 Atrial Fibrillation After SAVR: Optimizing management of peri-TAVR AF Presenter: Ankur Kalra May 06, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Conference News ACC 2017 Add-on LAA Occlusion in Cardiac Surgery Cuts Thromboembolism Risk in A-fib Patients L.A. McKeown March 21, 2017
News Conference News ACC 2017 SURTAVI Lends More Support to Use of TAVR in Intermediate-Risk Patients Todd Neale March 17, 2017
News Daily News Focused Update to Valve Guidelines Tackles Intermediate-Risk TAVR, Anticoagulation for A-fib Todd Neale March 15, 2017
News Daily News NOACs Seem to Perform Just Fine in Patients With A-fib and Most Types of Valvular Disease Todd Neale March 14, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
Presentation CRT 2017 Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Presenter: Chadi Alraies February 22, 2017